Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 8,890 shares at $61.66 ($547K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $547k KITE by VP, Product Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.09 | 2,171 | $133K | 24.2% |
| 2 | $61.66 | 6,719 | $414K | 75.8% |
| Total | $61.52 avg | 8,890 | $547K | 100% |
| Filing → |
| KITE | SELL | 2016-01-05 | $133K | — | Filing → |
| KITE | SELL | 2016-01-05 | $554K | — | Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |